Kevin L. Schwartz
Kevin L. Schwartz publishes mostly in Epidemiology, Infectious Diseases and Applied Microbiology and Biotechnology, on topics such as Antibiotic Use and Resistance, SARS-CoV-2 and COVID-19 Research and Vaccine Coverage and Hesitancy.
- World rank
- #259,909 of 7,710,434 ranked researchers
- Rank in Canada
- #8,930 of 183,316
- Works
- 228
- Citations
- 8k
- Citations per work
- 35.2
What does Kevin L. Schwartz research?
Kevin L. Schwartz's work is mostly in Medicine (34%), Immunology and Microbiology (13%), Health Professions (6%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Everything else9541.5%
- Health Sciences9340.7%
- Medicine7834.2%
- Health Professions156.5%
- Life Sciences2912.9%
- Immunology and Microbiology2912.9%
- Social Sciences114.9%
- Social Sciences114.9%
- 1Epidemiology15% of their works
- 2Infectious Diseases15% of their works
- 3Applied Microbiology and Biotechnology13% of their works
- 4General Health Professions6% of their works
- 5Health5% of their works
- 6Public Health, Environmental and Occupational Health4% of their works
Research topics
Which keywords describe Kevin L. Schwartz's research?
The keywords of their largest research topics: Epidemiology, Infectious Diseases, Antibiotic Resistance, Antimicrobial Stewardship, Antimicrobial Resistance, ACE2 Receptor, SARS-CoV-2 and Coronavirus.
- COVID-19
- Clinical Characteristics
- Community-Acquired Pneumonia
- Antibiotic Pharmacokinetics
- Catheter-Associated Infections
- COVID-19 Vaccine
- Coronavirus
- ACE2 Receptor
- Antimicrobial Stewardship
- Infectious Diseases
- Epidemiology
- Antibiotic Resistance
- Antimicrobial Resistance
- SARS-CoV-2
- Vaccine
- Vaccine Hesitancy
- Urinary Tract Infections
- Critically Ill Patients
- Pneumococcal Conjugate Vaccine
- Thrombosis
- Modeling
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.
All 21 words, with their numbers
- Epidemiology1665 topics
- Infectious Diseases992 topics
- Antibiotic Resistance811 topic
- Antimicrobial Stewardship811 topic
- Antimicrobial Resistance693 topics
- ACE2 Receptor632 topics
- SARS-CoV-2632 topics
- Coronavirus441 topic
- Vaccine441 topic
- COVID-19 Vaccine301 topic
- Vaccine Hesitancy301 topic
- Catheter-Associated Infections281 topic
- Urinary Tract Infections281 topic
- Antibiotic Pharmacokinetics211 topic
- Critically Ill Patients211 topic
- Community-Acquired Pneumonia201 topic
- Pneumococcal Conjugate Vaccine201 topic
- Clinical Characteristics191 topic
- Thrombosis191 topic
- COVID-19181 topic
- Modeling181 topic
Where does Kevin L. Schwartz work?
Kevin L. Schwartz's main affiliation in the publication record is Public Health Ontario, Canada.
How many publications and citations does Kevin L. Schwartz have?
OpenAlex counts 228 works and 8,029 citations for Kevin L. Schwartz, an h-index of 41, ranking #259,909 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about Kevin L. Schwartz. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.